Edvince AB

Neurology and Acute Brain Injury

Edvince AB focuses on clinical research in subarachnoid haemorrhage, with interest in the acute neurological consequences of bleeding in the brain and the medical needs that arise in the early treatment period.

  • Subarachnoid haemorrhage
  • Non-traumatic intracranial bleeding
  • Acute neurological care

The sponsor’s work is centered on therapeutic areas relevant to emergency management of SAH and the assessment of treatment-related safety in patients with brain haemorrhage.

Safety and Tolerability in Neurological Therapy

Research activity includes evaluation of the safety profile and tolerability of a treatment candidate in patients with subarachnoid haemorrhage, reflecting a clinical interest in treatment exposure during acute neurological disease.

  • Treatment safety
  • Tolerability assessment
  • Patient exposure in acute care

This area is closely tied to the management of patients requiring careful monitoring after a brain haemorrhage.

Emergency Medicine and Hospital-Based Care

The sponsor’s clinical focus extends to hospital-treated subarachnoid haemorrhage, a condition that typically requires urgent assessment and coordinated inpatient care.

  • Acute hospital treatment
  • Emergency neurological presentation
  • Inpatient monitoring

Its research interest aligns with medical settings where rapid intervention and close observation are essential in brain bleeding.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety of EDV2209 for Patients with Brain Bleeding (Subarachnoid Hemorrhage)

    Recruiting

    2 1
    Investigated diseases:
    Denmark